Literature DB >> 32990542

Protective Effect of Resveratrol against Glioblastoma: A Review.

Milad Ashrafizadeh1, Reza Mohammadinejad2, Tahereh Farkhondeh3, Saeed Samarghandian4.   

Abstract

BACKGROUND: One of the most common tumors of the central nervous system is Glioblastoma (GBM).
OBJECTIVE: There is not still an appropriate cure for this malignant tumor. Plant-derived natural products have demonstrated great potential in cancer therapy, and Resveratrol (Res) is among them. Therefore, the current study focused on the protective effect of resveratrol against glioblastoma and its underlying mechanism.
METHODS: PubMed, Medline, Scopus, Web of Science, and Google Scholar were searched by using the following keywords: Resveratrol, Glioblastoma, Brain tumor, Cancer therapy, Medicinal herbs to July 2020.
RESULTS: Res is a non-flavonoid polyphenol responsible for the protection of plants against pathogen attacks. Res has multiple pharmacological effects, including antioxidant, anti-inflammatory, anti-diabetic, and anti-tumor. Res is capable of penetration into the blood-brain barrier, making it suitable for brain tumor therapy. Besides, Res targets various molecular signaling pathways in cancer therapy.
CONCLUSION: In the present review, it was found that Res administration is beneficial in GBM therapy by inhibition of proliferation, viability, and migration via modulation of molecular pathways. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Resveratrol; brain tumor; cancer therapy; central nervous system; glioblastoma; medicinal herbs

Mesh:

Substances:

Year:  2021        PMID: 32990542     DOI: 10.2174/1871520620666200929151139

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  3 in total

Review 1.  Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment.

Authors:  Margarita Neganova; Junqi Liu; Yulia Aleksandrova; Sergey Klochkov; Ruitai Fan
Journal:  Cancers (Basel)       Date:  2021-12-01       Impact factor: 6.639

2.  Synthesis and Anticancer Activity of Bagasse Xylan/Resveratrol Graft-Esterified Composite Nanoderivative.

Authors:  Bin Zhao; Heping Li; Yue Su; Kexin Tian; Zhiming Zou; Wenli Wang
Journal:  Materials (Basel)       Date:  2022-07-26       Impact factor: 3.748

Review 3.  The Role of Natural Products as Inhibitors of JAK/STAT Signaling Pathways in Glioblastoma Treatment.

Authors:  Hanieh Fahmideh; Hooriyeh Shapourian; Rasol Moltafeti; Chanour Tavakol; Razieh Forghaniesfidvajani; Hamidreza Zalpoor; Mohsen Nabi-Afjadi
Journal:  Oxid Med Cell Longev       Date:  2022-09-19       Impact factor: 7.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.